Safety of nicotine replacement therapy in critically ill smokers: A retrospective cohort study
Safety of nicotine replacement therapy in critically ill smokers: A retrospective cohort study
Purpose
Nicotine replacement therapy (NRT) has been used to ameliorate nicotine withdrawal in the intensive care unit (ICU). Previous cohort studies have suggested an increased mortality with NRT use: methodological problems may call into question the validity of these findings. We undertook a retrospective cohort study to determine if NRT use was associated with adverse outcomes.
Methods
This retrospective cohort study was conducted in a 30-bed, university affiliated, teaching hospital ICU.
Results
We identified 423 smokers admitted over 2 years, of whom 73 received transdermal NRT. Cox proportional hazard regression models, with NRT modelled as a time-varying covariate, were used to test the hypothesis that NRT was associated with an altered ICU or hospital mortality. A second analysis utilized propensity scores. The unadjusted ICU and hospital mortalities were lower for the NRT group; although both differences were non-significant. The Cox models showed that, after adjustment for APACHE risk, age, sex and alcohol use, risk associated with NRT administration was not statistically different than non-administration for both ICU (hazard ratio 0.50, [95 % CI 0.20–1.24], p = 0.14) and hospital (hazard ratio 0.95, [95 % CI 0.52–1.75], p = 0.88) mortality. Similar findings occurred with the propensity matched analysis.
Conclusion
We were unable to demonstrate any harm associated with NRT, with the ICU model actually trending towards benefit. We conclude that a randomised, blinded, placebo controlled trial is required to assess adequately the safety and efficacy of NRT as a treatment in critically ill smokers.
1683–1688
Gillies, Michael A.
90dd48e4-c053-4464-b2c6-3b8e61d68306
McKenzie, C.A.
ec344dee-5777-49c5-970e-6326e82c9f8c
Whiteley, C.
c8ed19b8-e05d-4176-985f-bc2d80ff87a5
Beale, R.J.
fb3f80d5-3acf-496b-bc49-acb0c6caa6b2
Tibby, S.M.
e0bc1845-ca73-4294-82a1-8fe73f9bac8a
October 2012
Gillies, Michael A.
90dd48e4-c053-4464-b2c6-3b8e61d68306
McKenzie, C.A.
ec344dee-5777-49c5-970e-6326e82c9f8c
Whiteley, C.
c8ed19b8-e05d-4176-985f-bc2d80ff87a5
Beale, R.J.
fb3f80d5-3acf-496b-bc49-acb0c6caa6b2
Tibby, S.M.
e0bc1845-ca73-4294-82a1-8fe73f9bac8a
Gillies, Michael A., McKenzie, C.A., Whiteley, C., Beale, R.J. and Tibby, S.M.
(2012)
Safety of nicotine replacement therapy in critically ill smokers: A retrospective cohort study.
Intensive Care Medicine, 38, .
(doi:10.1007/s00134-012-2604-2).
Abstract
Purpose
Nicotine replacement therapy (NRT) has been used to ameliorate nicotine withdrawal in the intensive care unit (ICU). Previous cohort studies have suggested an increased mortality with NRT use: methodological problems may call into question the validity of these findings. We undertook a retrospective cohort study to determine if NRT use was associated with adverse outcomes.
Methods
This retrospective cohort study was conducted in a 30-bed, university affiliated, teaching hospital ICU.
Results
We identified 423 smokers admitted over 2 years, of whom 73 received transdermal NRT. Cox proportional hazard regression models, with NRT modelled as a time-varying covariate, were used to test the hypothesis that NRT was associated with an altered ICU or hospital mortality. A second analysis utilized propensity scores. The unadjusted ICU and hospital mortalities were lower for the NRT group; although both differences were non-significant. The Cox models showed that, after adjustment for APACHE risk, age, sex and alcohol use, risk associated with NRT administration was not statistically different than non-administration for both ICU (hazard ratio 0.50, [95 % CI 0.20–1.24], p = 0.14) and hospital (hazard ratio 0.95, [95 % CI 0.52–1.75], p = 0.88) mortality. Similar findings occurred with the propensity matched analysis.
Conclusion
We were unable to demonstrate any harm associated with NRT, with the ICU model actually trending towards benefit. We conclude that a randomised, blinded, placebo controlled trial is required to assess adequately the safety and efficacy of NRT as a treatment in critically ill smokers.
This record has no associated files available for download.
More information
Accepted/In Press date: 8 May 2012
e-pub ahead of print date: 23 May 2012
Published date: October 2012
Identifiers
Local EPrints ID: 479586
URI: http://eprints.soton.ac.uk/id/eprint/479586
ISSN: 0342-4642
PURE UUID: ed6ecf37-4b34-43b2-a6f8-83809bb6c0ee
Catalogue record
Date deposited: 26 Jul 2023 16:39
Last modified: 17 Mar 2024 04:23
Export record
Altmetrics
Contributors
Author:
Michael A. Gillies
Author:
C.A. McKenzie
Author:
C. Whiteley
Author:
R.J. Beale
Author:
S.M. Tibby
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics